Samuel JK Abraham, M.D. Ph.D.

JAD profile

Associate Editor

Term Expiration: 

12/31/2024

Affiliation(s): 

University of Yamanashi; Nichi-In Centre for Regenerative Medicine NCRM); GN Corporation Co Ltd

Lab URL: 

https://ncrm.org/

ORCID URL: 

https://www.j-alz.com/0000-0003-2646-2687

Areas of Interest: 

stem cells, regenerative medicine, immunology, Biomaterials, Biological response modifiers, Biosimilars, human neuroinflammation studies, aging

Biography & Research: 

• Completed primary medical degree in Tirunelveli Medical College in 1992, India. After a year in Pediatric surgery training, joined Yamanashi Medical University, Japan in 1993. Finished post-graduate training in Cardiac surgery in 1999 and got PhD. Since then with the Division of Pediatric Cardiac Surgery, Yamanashi University-Faculty of Medicine, Japan till date. • Lecturer, Centre for advancing clinical research, Yamanashi University; 2012~ till date • Started research in stem cells under the Nichi-In consortium, Tokyo, Japan in 2000 • Head, R&D, Co-Founder & Director, GN Corporation Co Ltd., Kofu, Japan.(http://www.gncorporation.com)-2002 Till Date • Founder & Director, Nichi-In Centre for Regenerative Medicine (NCRM), India; 2005~ till date • Distinguished Visiting Professor Award by the University of Toronto, CIHR TPRM 2012 & 2018. • Adjunct Faculty, INDICASAT, Panama, April 2012 • Visiting Professor, Tamilnadu Dr MGR Medical University, India (2010-2015) • Member, Scientific Board, International Stem Cell Academy (http://www.stemcell-academy.com/scientific-board/) Publications in Regenerative Medicine, Immunology, Neurology & Nutritional sciences: https://www.ncrm.org/feat/pub/index.htm Publications in Cardiothoracic and Vascular Surgery. https://www.crayawns.com/k2k/publication.htm Interests : 1. Translation of bench-side technologies for in vitro cell culture and tissue engineering using nanomaterials and polymers to the bed-side 2. Studying the complexity of physico-chemical-biological interactions by way of reproducing in vitro biomimicking systems with nanomaterials and environments 3. Immortalization and arrest of the process of aging of cells by subjecting them to various physico-chemical-biological environments and influences including zero-gravity of the outer space 4. Development and evolution of immune system through the ladder of phylogeny 5. Poly-extremo tolerance and adaptability across the ladder of phylogeny 6. Gut microbiome, immune systems, pre-biotics and metabolic syndrome 7. Gut-brain axis, pre-biotics and their linking of neurodevelopmental and neurodegenerative diseases Projects pursued: Corneal limbal stem cells, endothelial progenitors, (cesbank.org) Hybrid Artificial Corneal Prosthesis (hybridcornea.org) Hepatic progenitors for drug toxicology screening, Natural killer cell based immunotherapy for cancer & viral infections, (www.aietforcancer.org) Human monoclonal antibodies for cancer, Cell based therapies for anti-aging, In vitro expansion of human hematopoietic stem cells, Tissue engineering of human chondrocytes, Nanomaterial based scaffolds for cell culture and tissue engineering, Dental stem cells. Pre-biotics based control of microinflammation and their role in neurological illnesses Gut-brain axis, misfolding of alpha-synuclien and neurodegenerative diseases Anti-inflammatory and anti-fibrotic potentials of fungal polysaccharides Patents (applied/granted): A method for cultivating cells derived from corneal limbal tissue. Corneal endothelial precursor cell transplantation methodology employing a Nanocomposite gel sheet. A novel method of cryopreservation of various types of cells Influenza neutralizing antibody and method for screening the same Buccal epithelium Expanded and Encapsulated in Scaffold-Hybrid Approach to Urethral Stricture (BEES-HAUS) Enhancement of cells and increased NO production in microgravity Immune system enhancement and modulation in tackling viral infections and carcinogenesis Molecules of significance in curtailing organ fibrosis Method of beneficial reconstitution of Gut microbiome in tackling neurological illnesses Method to activate endogenous melatonin in children with Autism Spectrum Disorder Blogs : Nature Biotech Blog | Nature Bioengineering Community Profile:https://www.crayawns.com/k2k/briefprofile.htm Other Websites : http://www.metaniche.org http://www.chennaicellcluster.org http://www.angrennut.com